Did you know?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Atossa Therapeutics is $5.50, with a high forecast of $6.00 and a low forecast of $5.00. The consensus rating for Atossa Therapeutics stock is Buy based on the current 2 buy ratings for ATOS.Track Microsoft Corp (MSFT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIn December 2022, Atossa closed their previously announced investment in Dynamic Cell Therapies, Inc. (DCT), a privately held, venture capital backed, developer of CAR-T therapies. DCT is in the pre-clinical phase of developing controllable CAR-T cells to address difficult-to-treat cancers. Its platform technology of dynamic control of engineered T-cells is designed to improve the safety, […]Track Aeterna Zentaris Inc. (AEZS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Akebia Therapeutics Inc. (AKBA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsATOS US04962H5063 Biotechnology & Medical Research Market Closed - Nasdaq. Other stock markets. 04:00:00 2024-04-16 pm EDT 5-day change 1st Jan Change 1.54 USD -9.94%-16.30% +75.00%: Apr. 15: Atossa Therapeutics and Quantum Leap Healthcare Collaborative Announces I-SPY 2 Clinical Trial to Evaluate (Z-Endoxifen in Combination with Abemaciclib ...Track Akoustis Technologies Inc (AKTS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Novavax Inc (NVAX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAfter-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ...Find the latest Atos SE (ATO.PA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. ATOS, a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that the (Z)-endoxifen arm of the ongoing Phase 2 I-SPY 2 clinical trial has fully enrolled.In the study, (Z)-endoxifen, Atossa's proprietary ...Track Acumen Pharmaceuticals Inc (ABOS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsATOS Stock 12 Month Forecast. $5.33. (231.06% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Atossa Therapeutics in the last 3 months. The average price target is $5.33 with a high forecast of $6.00 and a low forecast of $4.00. The average price target represents a 231.06% change from the last price of $1.61.Feb 12, 2024 · Atossa Therapeutics ( NASDAQ: ATOS) traded higher on Monday after H.C. Wainwright launched its coverage with a Buy rating and a $4 per share target, citing the prospects of its lead asset, Z ...Atossa Therapeutics (ATOS) added ~17% Wednesday on the news that a mid-stage trial for its breast cancer therapy (Z)-endoxifen reached 30% enrollment. Read more here.Anatoly Gavrilov. Introducing Litepaper, a newsletter by Stocktwits. Your lens into the world of crypto. The latest messages and market ideas from Anatoly Gavrilov (@Atos) on Stocktwits. The largest community for investors and traders.Track Adma Biologics Inc (ADMA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Ocugen Inc (OCGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update. Find the latest Atossa Therapeutics, Inc. (ATOS) stock quote, history, news and other vital information to help you with your stock trading and investing.People with pump this up and spread rumors about this being a huge COVID play, stocktwits will go off about how an announcement is incoming, etc. Then people will inevitably be disappointed that there isn’t more information provided about the trial during this conference. Or they will anticipate a dump and will sell. Rinse and repeat.Track Immunic Inc (IMUX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtossa Therapeutics Inc. ATOS | Complete Atossa Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial …

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Atossa Therapeutics (ATOS – Research Report). The associated price target is $4.00. The associated price target is $4.00.Atossa to begin Phase 2 Study of (Z)-endoxifen in 4th Quarter SEATTLE, Oct. 24, 2022 — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology with a current focus on breast cancer, announced today that the U.S. Food and Drug Administration […]Atos is a global leader in digital transformation with c. 95,000 employees and annual revenue of c. € 11 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 69 countries. A pioneer in decarbonization services and products, Atos is committed ...Discover historical prices for ATOS stock on Yahoo Finance. View daily, weekly or monthly format back to when Atossa Therapeutics, Inc. stock was issued.Catalysts: The road ahead: 1.ATOS is set to present at a COVID conference on the 26th. 2. Successful Phase 1 result with nasal spray: $300M-500M market cap. 3. Good Phase 2 result from Endoxifen: $1B+ market cap. Stock Price Target: High 7.50 Median 6.25 Low 5.00 Average 6.25. Reply.

Track Moderna Inc (MRNA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtossa Therapeutics released its earnings results on Apr 01, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.065 by $0.005. Is Atossa Therapeutics overvalued? According to Wall Street analysts Atossa Therapeutics’s price is currently Undervalued.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Complete Atossa Therapeutics Inc. stock information by . Possible cause: Track Seelos Therapeutics Inc (SEEL) Stock Price, Quote, latest community messages, ch.